Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lai, Yin-Chieh
Huang, Ming-Chyi
Chen, Hsi-Chung
Lu, Ming-Kun
Chiu, Yi-Hang
Shen, Winston W.
Lu, Ru-Band
and
Kuo, Po-Hsiu
2014.
Familiality and clinical outcomes of sleep disturbances in major depressive and bipolar disorders.
Journal of Psychosomatic Research,
Vol. 76,
Issue. 1,
p.
61.
Hawkins, Misty A.W.
Callahan, Christopher M.
Stump, Timothy E.
and
Stewart, Jesse C.
2014.
Depressive Symptom Clusters as Predictors of Incident Coronary Artery Disease.
Psychosomatic Medicine,
Vol. 76,
Issue. 1,
p.
38.
Dale, Elena
Zhang, Hong
Leiser, Steven C
Xiao, Yixin
Lu, Dunguo
Yang, Charles R
Plath, Niels
and
Sanchez, Connie
2014.
Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.
Journal of Psychopharmacology,
Vol. 28,
Issue. 10,
p.
891.
Lam, Raymond W
Kennedy, Sidney H
McIntyre, Roger S
and
Khullar, Atul
2014.
Cognitive Dysfunction in Major Depressive Disorder: Effects on Psychosocial Functioning and Implications for Treatment.
The Canadian Journal of Psychiatry,
Vol. 59,
Issue. 12,
p.
649.
Bobrov, A. E.
Krasnoslobodtseva, L. A.
Mutnykh, E. M.
and
Kursakov, A. A.
2014.
Cognitive impairment in depression and potential applications of antidepressants with procognitive effects.
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova,
Vol. 114,
Issue. 11. Vyp. 2,
p.
10.
Case, Stephanie M.
and
Stewart, Jesse C.
2014.
Race/ethnicity moderates the relationship between depressive symptom severity and C-reactive protein: 2005–2010 NHANES data.
Brain, Behavior, and Immunity,
Vol. 41,
Issue. ,
p.
101.
Wang, Yuan-Pang
and
Gorenstein, Clarice
2014.
Attitude and Impact of Perceived Depression in the Workplace.
International Journal of Environmental Research and Public Health,
Vol. 11,
Issue. 6,
p.
6021.
Harada, E.
Kato, M.
Fujikoshi, S.
Wohlreich, M. M.
Berggren, L.
and
Tokuoka, H.
2015.
Changes in energy during treatment of depression: an analysis of duloxetine in double‐blind placebo‐controlled trials.
International Journal of Clinical Practice,
Vol. 69,
Issue. 10,
p.
1139.
McGirr, Alexander
Van den Eynde, Frederique
Tovar-Perdomo, Santiago
Fleck, Marcelo P.A.
and
Berlim, Marcelo T.
2015.
Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: An open label trial.
Journal of Affective Disorders,
Vol. 173,
Issue. ,
p.
216.
2015.
Cognitive Impairment in Major Depressive Disorder.
p.
229.
McGirr, A.
Berlim, M. T.
Bond, D. J.
Fleck, M. P.
Yatham, L. N.
and
Lam, R. W.
2015.
A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.
Psychological Medicine,
Vol. 45,
Issue. 4,
p.
693.
Culpepper, Larry
Muskin, Philip R.
and
Stahl, Stephen M.
2015.
Major Depressive Disorder: Understanding the Significance of Residual Symptoms and Balancing Efficacy with Tolerability.
The American Journal of Medicine,
Vol. 128,
Issue. 9,
p.
S1.
Bétry, Cécile
Etiévant, Adeline
Pehrson, Alan
Sánchez, Connie
and
Haddjeri, Nasser
2015.
Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 58,
Issue. ,
p.
38.
Gonda, Xenia
Pompili, Maurizio
Serafini, Gianluca
Carvalho, Andre F.
Rihmer, Zoltan
and
Dome, Peter
2015.
The role of cognitive dysfunction in the symptoms and remission from depression.
Annals of General Psychiatry,
Vol. 14,
Issue. 1,
Pehrson, Alan L.
Leiser, Steven C.
Gulinello, Maria
Dale, Elena
Li, Yan
Waller, Jessica A.
and
Sanchez, Connie
2015.
Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine.
European Journal of Pharmacology,
Vol. 753,
Issue. ,
p.
19.
2015.
Cognitive Impairment in Major Depressive Disorder.
p.
1.
Targum, Steven D.
Wedel, Pamela C.
and
Fava, Maurizio
2015.
Changes in cognitive symptoms after a buspirone–melatonin combination treatment for Major Depressive Disorder.
Journal of Psychiatric Research,
Vol. 68,
Issue. ,
p.
392.
Messer, Thomas
2015.
Freudloser Ingenieur mit Konzentrationsproblemen.
MMW - Fortschritte der Medizin,
Vol. 157,
Issue. 16,
p.
63.
Sachs, Gabriele
and
Erfurth, Andreas
2015.
Kognition bei depressiven Störungen.
psychopraxis. neuropraxis,
Vol. 18,
Issue. 5,
p.
172.
Hosenfeld, Bettina
Bos, Elisabeth H.
Wardenaar, Klaas J.
Conradi, Henk Jan
van der Maas, Han L. J.
Visser, Ingmar
and
de Jonge, Peter
2015.
Major depressive disorder as a nonlinear dynamic system: bimodality in the frequency distribution of depressive symptoms over time.
BMC Psychiatry,
Vol. 15,
Issue. 1,